Total Customers Served: 77,291 – Sales Per Customer: JPY 6,461 – Customer Repeat Ratio: 79.6%
May 2022_Number of Salons
May 2022_Total Customers Served
May 2022_Sales per Customer
May 2022_Repeat Ratio
May 2022_Operation Ratio
NEW YORK, June 21, 2022 (GLOBE NEWSWIRE) — MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan (the “Company”), today announced its major Key Performance Indicators, or KPIs, updated for the month of May 2022. Data is provided for all salons for which comparative financial and customer data is available and excludes certain salons where such information is not available.
The following monthly KPIs provide insight into the business fundamentals and progress of the Company, updated for the month of May 2022.
Number of Salons(*1) | Number of Salons with Data(*2) | Total Customers Served(*3) | Sales per Customer(*4) | Repeat Ratio(*5) | Operation Ratio(*6) | |
May-21 | 313 | 212 | 66,604 | JPY 6,370 | 80.6% | 48.7% |
June-21 | 313 | 219 | 68,069 | JPY 6,350 | 81.2% | 48.6% |
July-21 | 314 | 220 | 70,912 | JPY 6,498 | 81.0% | 48.1% |
August-21 | 315 | 221 | 66,323 | JPY 6,592 | 81.3% | 46.5% |
September-21 | 316 | 221 | 65,130 | JPY 6,428 | 82.0% | 46.7% |
October-21 | 316 | 221 | 68,608 | JPY 6,486 | 83.3% | 48.9% |
November-21 | 316 | 221 | 65,569 | JPY 6,466 | 81.9% | 47.7% |
December-21 | 312 | 221 | 71,173 | JPY 6,634 | 81.7% | 50.5% |
January-22 | 312 | 221 | 62,747 | JPY 6,570 | 82.4% | 48.2% |
February-22 | 310 | 219 | 54,443 | JPY 6,662 | 83.8% | 46.4% |
March-22 | 310 | 217 | 61,417 | JPY 6,595 | 82.4% | 46.5% |
April-22 | 309 | 232 | 69,986 | JPY 6,616 | 82.0% | 48.3% |
May-22 | 308 | 232 | 77,291 | JPY 6,461 | 79.6% | 50.1% |
(*1) Number of Salons: Includes our directly-operated salons, and franchisees’ salons.
(*2) Number of Salons with Data: The number of salons for which comparable financial and customer data is available.
(*3) Total Customers Served: The number of customers served at salons for which comparative financial and customer data is available.
(*4) Sales Per Customer: The ratio of total salon sales to number of treated customers at all salons for which comparable financial and customer data is available.
(*5) Repeat Ratio: The ratio of repeat customer visits to total customer visits in the applicable month for all salons for which comparable financial and customer data is available.
(*6) Operation Ratio: The ratio of therapists’ in-service time to total therapists’ working hours (including stand-by time) for the applicable month for all salons for which comparable financial and customer data is available.
*Since July 2021, the salon operation business has been managed by Wing Inc., which is a wholly-owned subsidiary of the Company.
About MEDIROM Healthcare Technologies Inc.
MEDIROM a holistic healthcare company, operates 308 (as of May 31, 2022) relaxation salons across Japan, Re.Ra.Ku®, being its leading brand, and provides healthcare services. In 2015, MEDIROM entered the health tech business, and launched new healthcare programs using on-demand training app called “Lav®”, which is developed by the company. MEDIROM also entered the device business in 2020 and is developing a smart tracker “MOTHER Bracelet” (formerly known as “MOTHER Tracker®”). MEDIROM hopes that its diverse health related services and products offering will help it collect and manage healthcare data from users and customers and enable it to become a leader in big data in the healthcare industry. For more information, visit https://medirom.co.jp/en
Forward-Looking Statements
Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about the Company’s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,” “design,” “target,” “aim,” “hope,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “predict,” “project,” “potential,” “goal,” or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to the Company’s future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company’s control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to the Company’s operations, results of operations, growth strategy and liquidity. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/371210b7-87cd-41c8-bd83-6bc362535143
https://www.globenewswire.com/NewsRoom/AttachmentNg/5e05c8a5-a088-40f7-a5f2-15247bf1cf5c
https://www.globenewswire.com/NewsRoom/AttachmentNg/b4b4f57f-e810-41ec-9086-ca589aa8ea5d
https://www.globenewswire.com/NewsRoom/AttachmentNg/11360dfe-8fbd-4fbf-8b37-7c4b9aacf7fa
https://www.globenewswire.com/NewsRoom/AttachmentNg/22086c67-0c4e-4845-9fa9-6c1fa4a00566
CONTACT: Contacts Investor Relations Team ir@medirom.co.jp Or U.S. Investor Contact Robert Blum, Joe Diaz, Joe Dorame Lytham Partners, LLC 602-889-9700 MRM@lythampartners.com
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…